FIELD: biotechnology.
SUBSTANCE: invention is related to combination of two recombinant expression plasmids - pBudK-coVEGF-coANG and pBudK-coGDNF.
EFFECT: invention is effective for the treatment of conditions associated with circulatory failure, in particular in cardiovascular surgery, as well as treatment of traumatic injuries to skeletal muscle, using a combination of genes encoding the synthesis of proangiogenic and neurotrophic factors.
7 cl, 3 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REGULATING NERVOUS FIBERS OF BLOOD VESSELS | 2018 |
|
RU2682160C2 |
| METHOD FOR STIMULATING NEUROGENERATION BY GENETIC MAKE-UPS | 2011 |
|
RU2459630C1 |
| METHOD FOR STIMULATING RESTORATION OF TISSUE INNERVATION FOLLOWING INJURIES AND ISCHEMIA BY MEANS OF VECTOR CONSTRUCT | 2013 |
|
RU2538621C2 |
| AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
| METHOD FOR REPARATIVE ANGIOGENESIS STIMULATION AND CONNECTIVE TISSUE REGENERATION IN CASE OF ITS DAMAGE, BY THE GENETIC THERAPY METHOD USING SPECIES-SPECIFIC VEGF AND FGF2 PROTEIN FACTORS GENES IN VETERINARY MEDICINE, AND GENETIC STRUCTURE FOR IMPLEMENTATION OF METHOD | 2015 |
|
RU2614665C1 |
| METHOD OF STIMULATING REPARATIVE ANGIOGENESIS AND REGENERATION OF SKIN OF DOGS WITH DAMAGE THEREOF BY GENE THERAPY USING SPECIES-SPECIFIC GENES OF PROTEIN FACTORS VEGF AND FGF2 IN VETERINARY SCIENCE AND GENETIC CONSTRUCT FOR REALIZING DECLARED METHOD | 2019 |
|
RU2719513C1 |
| METHOD FOR STIMULATING ANGIOGENESIS USING GENETICALLY MODIFIED UMBILICAL CORD BLOOD CELLS | 2017 |
|
RU2663470C2 |
| METHOD FOR STIMULATING RECOVERED PERIPHERAL TISSUE INNERVATION | 2011 |
|
RU2486918C1 |
| METHOD FOR TREATING TRAUMATIC SPINAL CORD INJURY | 2021 |
|
RU2758760C1 |
| METHOD OF STIMULATING RECOVERY OF DAMAGED TISSUE INNERVATION | 2014 |
|
RU2563541C1 |
